Pan, J.; Zeng, W.; Jia, J.; Shi, Y.; Wang, D.; Dong, J.; Fang, Z.; He, J.; Yang, X.; Zhang, R.;
et al. A Novel Therapeutic Tumor Vaccine Targeting MUC1 in Combination with PD-L1 Elicits Specific Anti-Tumor Immunity in Mice. Vaccines 2022, 10, 1092.
https://doi.org/10.3390/vaccines10071092
AMA Style
Pan J, Zeng W, Jia J, Shi Y, Wang D, Dong J, Fang Z, He J, Yang X, Zhang R,
et al. A Novel Therapeutic Tumor Vaccine Targeting MUC1 in Combination with PD-L1 Elicits Specific Anti-Tumor Immunity in Mice. Vaccines. 2022; 10(7):1092.
https://doi.org/10.3390/vaccines10071092
Chicago/Turabian Style
Pan, Jiayi, Wuyi Zeng, Jiangtao Jia, Yi Shi, Danni Wang, Jun Dong, Zixuan Fang, Jiashan He, Xinyu Yang, Rong Zhang,
and et al. 2022. "A Novel Therapeutic Tumor Vaccine Targeting MUC1 in Combination with PD-L1 Elicits Specific Anti-Tumor Immunity in Mice" Vaccines 10, no. 7: 1092.
https://doi.org/10.3390/vaccines10071092
APA Style
Pan, J., Zeng, W., Jia, J., Shi, Y., Wang, D., Dong, J., Fang, Z., He, J., Yang, X., Zhang, R., He, M., Huang, M., Fu, B., Zhong, B., & Liu, H.
(2022). A Novel Therapeutic Tumor Vaccine Targeting MUC1 in Combination with PD-L1 Elicits Specific Anti-Tumor Immunity in Mice. Vaccines, 10(7), 1092.
https://doi.org/10.3390/vaccines10071092